The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…

Johnson & Johnson

Launching a drug? Be prepared to show it's cost-effective up front, consultant says

What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J

GSK tops pharma in access work, report says; J&J, Novartis round out top 3

Under drug-cost attack, Big Pharma CEOs raise the value-based pricing flag

With pharma lobbying hard, California's contentious Prop 61 is now a toss-up, poll shows

Already facing $200M in damages, J&J seeks to move talc cases out of St. Louis

Jury smacks J&J with $67M in talc-powder damages, its third defeat this year

J&J clot fighter battles Pfizer/Bristol for warfarin switches in red-hot market share race

Remicade patients are OK to switch to Celltrion's biosim, study shows, as Pfizer gears up for U.S. rollout

Pfizer loads up for Remicade biosim launch, with $4.5B J&J brand in its sights